Document is current

Article History

Received: 10 May 2025

Accepted: 13 August 2025

First Online: 29 September 2025

Declarations

:

: This study was approved by the Okayama University Certified Review Board prior to initiation (approval no., CRB21-004). It was registered with the Japan Registry of Clinical Trials (jRCTs061210040) as a specified clinical trial involving the use of unapproved or off-label drugs. The participants reviewed the study documents and received individual counseling to ensure an understanding of the study procedures and associated risks prior to providing written consent for study participation in accordance with the Declaration of Helsinki. All patients provided written informed consent to have their data collected in our institutional database used for present and future studies.

: Written informed consent was obtained from the patients for publication of this case report and any accompanying images. Copies of the written consent are available for review by the Editor-in-Chief of this journal.

: The authors have no conflicts of interest to declare.